Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
SS Innovations International, Inc. (OTC: SSII) has announced a significant milestone: over 2,000 successful robotic surgeries performed using its SSi Mantra Surgical Robotic System, primarily in India. This achievement underscores the company's commitment to making advanced surgical technologies accessible globally.
The SSi Mantra system has been praised for its ergonomic design and precise controls, facilitating minimally invasive procedures and improving patient outcomes. It has been installed in numerous Tier 2 and Tier 3 cities across India, as well as in Nepal, marking the country's first surgical robot.
Of the 2,000 surgeries, 123 were cardiac cases, demonstrating the system's versatility. The company's focus on 'democratizing access' and 'decentralizing excellence' in healthcare is evident in its efforts to make world-class robotic surgery affordable and accessible to a larger global population.
SS Innovations International, Inc. (OTC: SSII) ha annunciato un traguardo importante: oltre 2.000 interventi chirurgici robotici riusciti eseguiti utilizzando il suo Sistema Robotico Chirurgico SSi Mantra, principalmente in India. Questo risultato sottolinea l'impegno dell'azienda a rendere le tecnologie chirurgiche avanzate accessibili a livello globale.
Il sistema SSi Mantra è stato lodato per il suo design ergonomico e controlli precisi, facilitando procedure minimamente invasive e migliorando i risultati per i pazienti. È stato installato in numerose città di livello 2 e 3 in tutta l'India, così come in Nepal, segnando il primo robot chirurgico del paese.
Dei 2.000 interventi, 123 erano casi cardiaci, dimostrando la versatilità del sistema. L'attenzione dell'azienda a 'democratizzare l'accesso' e 'decentralizzare l'eccellenza' nella sanità è evidente nei suoi sforzi per rendere la chirurgia robotica di classe mondiale accessibile e conveniente per una popolazione globale più ampia.
SS Innovations International, Inc. (OTC: SSII) ha anunciado un hito significativo: más de 2.000 cirugías robóticas exitosas realizadas con su Sistema Robótico Quirúrgico SSi Mantra, principalmente en India. Este logro subraya el compromiso de la empresa de hacer que las tecnologías quirúrgicas avanzadas sean accesibles a nivel mundial.
El sistema SSi Mantra ha sido elogiado por su diseño ergonómico y controles precisos, facilitando procedimientos mínimamente invasivos y mejorando los resultados de los pacientes. Se ha instalado en numerosas ciudades de nivel 2 y 3 en toda la India, así como en Nepal, marcando el primer robot quirúrgico del país.
De las 2.000 cirugías, 123 eran casos cardíacos, demostrando la versatilidad del sistema. El enfoque de la empresa en 'democratizar el acceso' y 'descentralizar la excelencia' en la atención médica es evidente en sus esfuerzos por hacer que la cirugía robótica de clase mundial sea asequible y accesible para una mayor población global.
SS Innovations International, Inc. (OTC: SSII)는 중요한 이정표를 발표했습니다: 2,000건 이상의 성공적인 로봇 수술이 주로 인도에서 SSi Mantra 수술 로봇 시스템을 사용하여 수행되었습니다. 이 성과는 첨단 수술 기술을 전 세계적으로 접근 가능하게 만들겠다는 회사의 약속을 강조합니다.
SSi Mantra 시스템은 인체 공학적 디자인과 정밀한 조작로 찬사를 받아 최소 침습 절차를 용이하게 하고 환자 결과를 개선하고 있습니다. 이 시스템은 인도의 여러 2급 및 3급 도시와 네팔에 설치되어 있으며, 이 나라의 첫 번째 수술용 로봇입니다.
2,000건의 수술 중 123건은 심장 사례였으며, 이는 시스템의 다재다능성을 보여줍니다. 건강 관리에서 '접근 민주화'와 '탁월성 분산'에 대한 회사의 초점은 세계적 수준의 로봇 수술을 더 많은 글로벌 인구에게 저렴하고 접근 가능하게 만드는 노력에서 분명히 드러납니다.
SS Innovations International, Inc. (OTC: SSII) a annoncé une étape importante : plus de 2 000 chirurgies robotiques réussies réalisées grâce à son Système Robotique Chirurgical SSi Mantra, principalement en Inde. Cet accomplissement souligne l'engagement de la société à rendre les technologies chirurgicales avancées accessibles à l'échelle mondiale.
Le système SSi Mantra a été salué pour son design ergonomique et ses contrôles précis, facilitant les procédures peu invasives et améliorant les résultats pour les patients. Il a été installé dans de nombreuses villes de niveau 2 et 3 à travers l'Inde, ainsi qu'au Népal, marquant le premier robot chirurgical du pays.
Sur les 2 000 chirurgies, 123 étaient des cas cardiaques, démontrant la polyvalence du système. L'accent mis par l'entreprise sur 'la démocratisation de l'accès' et 'la décentralisation de l'excellence' en matière de santé est évident dans ses efforts pour rendre la chirurgie robotique de classe mondiale abordable et accessible à une population mondiale plus large.
SS Innovations International, Inc. (OTC: SSII) hat einen bedeutenden Meilenstein bekannt gegeben: Über 2.000 erfolgreiche robotergestützte Operationen wurden mit dem SSi Mantra Chirurgischen Robotersystem, hauptsächlich in Indien, durchgeführt. Dieser Erfolg unterstreicht das Engagement des Unternehmens, fortschrittliche chirurgische Technologien weltweit zugänglich zu machen.
Das SSi Mantra System wurde für sein ergonomisches Design und präzise Steuerung gelobt, was minimalinvasive Eingriffe erleichtert und die Patientenergebnisse verbessert. Es wurde in zahlreichen Städten der Kategorien 2 und 3 in Indien sowie in Nepal installiert und markiert den ersten chirurgischen Roboter des Landes.
Von den 2.000 Operationen waren 123 kardiologische Fälle, was die Vielseitigkeit des Systems demonstriert. Der Fokus des Unternehmens auf 'Zugangsdemokratisierung' und 'Dezentralisierung von Exzellenz' im Gesundheitswesen zeigt sich in seinen Bemühungen, weltweit zugängliche und erschwingliche robotergestützte Chirurgie anzubieten.
- None.
- None.
FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, announced that it has now successfully completed over 2,000 robotic surgeries, primarily in India, using its SSi Mantra Surgical Robotic System (the “SSi Mantra”).
The significance of the 2,000 surgeries extends beyond mere numbers; it embodies a critical response to a pressing need in the medical community. As global disparities in healthcare persist, SS Innovations has emerged as a leader in providing advanced surgical solutions that are accessible to all. The Company’s guiding principles of “democratizing access” and “decentralizing excellence” reflect its dedication to making world-class healthcare attainable for every patient, irrespective of their socio-economic background.
The SSi Mantra’s impact is already being felt in hospitals throughout India where it has been installed. Surgeons have praised its ergonomic design and precise controls, which facilitate minimally invasive procedures and improve patient outcomes. By minimizing recovery time and reducing the risk of complications, the SSi Mantra has become an invaluable tool in surgical suites, particularly in resource-constrained environments where access to advanced technologies has historically been limited due to the relative exorbitant cost associated with such technology.
Notably, the SSi Mantra has also been installed in many Tier 2 and Tier 3 cities across India, including Moradabad, Hisar, Coimbatore, Rohtak, and Cuttack, where communities are now reaping the benefits of innovative surgical technologies. Furthermore, the SSi Mantra also marks a significant milestone as Nepal’s first surgical robot, bringing renewed hope for advanced medical care to that nation.
Among the 2,000 surgeries performed, 123 were cardiac cases. Each procedure addresses varying complexities, highlighting the system’s versatility and adaptability in handling intricate surgical procedures.
To celebrate this milestone, SS Innovations Founder, Chairman, and CEO, Dr. Sudhir Srivastava expressed his gratitude to the entire team. “It is the spirit of our engineers, their faith in the system, and their commitment to improving lives that has brought us this far”.
Dr. Vishwa Srivastava, President and COO of SS Innovations, remarked, “Our mission as a digital healthcare company is to democratize global access to the latest technologies. This milestone underscores the impact of our innovations and drives us forward in our journey to improve surgical outcomes globally.”
The success of the SSi Mantra Surgical Robotic System in India has resulted in robust quality and safety data as well as clinical patient-centric outcomes. This should be helpful in not only continuing SS Innovation’s mission to provide quality care to patients across the globe but also of value in seeking further regulatory approval in other markets.
About SS Innovations International, Inc.:
SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at ssinnovations.com or LinkedIn for updates.
About SSI Mantra:
Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 80 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving FDA approval to market and CE Mark approval in the second half of 2025.
Forward-Looking Statements:
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International, Inc.’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
YouTube: https://www.youtube.com/@ssinnovations
For media inquiries, please contact:
press@ssinnovations.org
+1-212-739-0300
A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/60c19822-1f18-4438-a100-2f7290ba85d4
FAQ
How many surgeries has the SSi Mantra Surgical Robotic System completed?
Where has the SSi Mantra system been installed?
How many cardiac cases were performed using the SSi Mantra system?
What is the mission of SS Innovations International Inc. (SSII)?
When does SS Innovations (SSII) expect to receive FDA and CE Mark approval for the SSi Mantra system?
